Form DEFA14A INTERPACE BIOSCIENCES,

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a)

of the Securities Exchange Act of 1934

(Amendment No. )

 

Filed by the Registrant	☒
Filed by a Party other than the Registrant	☐

 

Check the appropriate box:

 

☐	Preliminary Proxy Statement
☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐	Definitive Proxy Statement
☒	Definitive Additional Materials
☐	Soliciting Material Pursuant to § 240.14a-12

 

INTERPACE BIOSCIENCES, INC.

(Name of Registrant as Specified in Its Charter)

 

Not applicable

(Name of Person(s) Filing Proxy Statement, if other than the registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

☒	No fee required.
☐	Fee paid previously with preliminary materials.
☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• tms Selects FourKites to Ensure Seamless Global Delivery of High-Demand Consumer Goods
• Ascend Technology Group Named 2026 Business Excellence Award Winner by the Greater Omaha Chamber of Commerce
• Zillow Group Securities Fraud Class Action Arising from Alleged Anticompetitive Agreement and Related Regulatory Risks – Investors May Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC